Helius medical technologies.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s …C/O HELIUS MEDICAL TECHNOLOGIES, INC. 642 NEWTOWN YARDLEY ROAD, SUITE 100 (Street) NEWTOWN: PA: 18940 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol HELIUS MEDICAL TECHNOLOGIES, INC. [ HSDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X:Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s...Previously, Mr. Buckman served as chief executive officer and chairman of Pathway Medical Technologies, Inc, a medical device company focused on treatment of peripheral arterial disease from September 2008 to February 2012; as chief executive officer of Devax, Inc, a developer and manufacturer of drug-eluting stents from December 2006 to ... Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that its President and Chief Executive Officer, Dane Andreeff, will be presenting at the NobleCon 19th Annual Emerging Growth Equity Conference. The event is set to take place on Tuesday, December 5, 2023, at 2:00 pm ET in Boca Raton, Florida.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Nov 30, 2023 · Helius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06M. November 30, 2023 | Tomorrow Investor (Ad) The Only Practical Solution to the World’s Looming Energy Crisis. There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants! Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Mar 22, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Jul 27, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ...

Apr 27, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Helius Medical Technologies, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Previously, Mr. Buckman served as chief executive officer and chairman of Pathway Medical Technologies, Inc, a medical device company focused on treatment of peripheral arterial disease from September 2008 to February 2012; as chief executive officer of Devax, Inc, a developer and manufacturer of drug-eluting stents from December 2006 to ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Contact Helius Our Headquarters642 Newtown Yardley Rd., Ste 100Newtown, PA 18940Phone: +1 877-564-0008 The Portable Neuromodulation Stimulator (PoNS®) is an authorized medical device in the US. The PoNS device is indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS) and is to be usedHelius Medical Technologies Inc is a neurological research company. The Company explores neuroplasticity, electrotactile stimulation and neuromodulation. Address. 41 University Drive Suite 400 ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Helius Medical Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), certifies that: 1. The Certificate of Amendment to the Certificate of Incorporation that was filed with the Delaware Secretary of State on August 15, 2023 requires correction as permitted by Section 103(f) of ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ...Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...

NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius’ Chief Medical Officer, will present...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...

Our next medical device stock short idea is Helius Medical Technologies (NASDAQ:HSDT). It is a pre-revenue, $200M+ market cap company claiming its only product, the Portable Neuromodulation ...Aug 23, 2022 · Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness. Helius’ origin stems from the early 1990s, and the ... Helius has studied the PoNS® to determine whether its use in combination Research - Helius Medical Technologies Our Research includes Helius-sponsored Clinical Trials and future PoNS Therapy studies on neurological diseases and disorders, such as stroke, multiple sclerosis and cerebral palsy. Aug 23, 2022 · Helius Medical Technologies, Inc., (“Helius”), is a neurotech company in the medical device industry, focused on neurological wellness. Helius’ origin stems from the early 1990s, and the ... Helius Medical Technologies, Inc. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy ...Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself.

Nov 24, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%.

NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief. November 30, 2023.

Apple announced several things yesterday, but ResearchKit, the company's new medical research and health platform, is clearly the technology with the most potential to actually improve people's lives. Services like it are already at work ar...Aug 16, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Apr 17, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief. November 30, 2023.Dec 1, 2023 · A high-level overview of Helius Medical Technologies, Inc. (HSDT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius brings together the world’s best talent to succeed in our ongoing mission. Together, we work passionately to develop and deliver easy-to-use technology for neurological wellness. If you want to join us in our mission, we want to hear from you. Email your letter of interest and resume to [email protected]. Dec 1, 2023 · A high-level overview of Helius Medical Technologies, Inc. (HSDT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Mar 23, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Sep 13, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Helius Medical Technologies has extended by six months a program that allows multiple sclerosis (MS) patients in the U.S. to access its Portable Neuromodulation Stimulator (PoNS) device at a ...Find the latest Helius Medical Technologies Inc (HSDT) discussion and analysis from iHub's community of investors.Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Instagram:https://instagram. howard marks start engineprincess diana jewelry auctioninvesco canadabest insurance for electricians AI is frequently cited as a miracle worker in medicine, especially in screening processes, where machine learning models boast expert-level skills in detecting problems. But like so many technologies, it’s one thing to succeed in the lab, q... reddit robinhoodhighest monthly dividend etf Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... adc stock dividend Helius Medical Technologies, Inc (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET. Company Participants. Michelle Gable Bilski - In-Site Communications, IR.Helius has studied the PoNS® to determine whether its use in combination Research - Helius Medical Technologies Our Research includes Helius-sponsored Clinical Trials and future PoNS Therapy studies on neurological diseases and disorders, such as stroke, multiple sclerosis and cerebral palsy. Helius Medical Technologies last released its earnings results on November 9th, 2023. The reported ($5.49) earnings per share for the quarter. The firm earned $0.14 …